Showing results (31-40 of 52) with videos related to
Sort By:
Pageof 6
Vaccine|July 2, 2011
Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix(®)) in adults 55 years of age and over: a sub-analysis of four trialsPierre Van Damme, Peter McIntyre, Emmanuel Grimprel, et al.The Journal of Pediatrics|March 23, 2010
Booster vaccination after neonatal priming with acellular pertussis vaccineMarkus Knuf, Heinz-Josef Schmitt, Jeanne-Marie Jacquet, et al.Vaccine|March 7, 2006
Interchangeability of two diphtheria and tetanus toxoids, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate vaccines as a fourth dose in 15-20-month-old toddlersScott A Halperin, Bruce Tapiero, Barbara Law, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2010
Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adultsJussi Mertsola, Olivier Van Der Meeren, Qiushui He, et al.Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|January 15, 2025
Adherence to Recommendations and Yield of Critical Care EEG Monitoring: A Prospective Multicentric StudyFlavio Bellante, Susana Ferrao Santos, Ludovic Gérard, et al.Human Vaccines|August 12, 2008
Immunogenicity and reactogenicity of two diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccines administered at 3, 5 and 11-12 months of ageTerhi M Kilpi, Sven Arne Silfverdal, Lennart Nilsson, et al.Human Vaccines & Immunotherapeutics|November 11, 2020
Safety and immunogenicity of a new Sabin inactivated poliovirus vaccine candidate produced on the PER.C6® cell-line: a phase 1 randomized controlled trial in adultsIsabel Leroux-Roels, Geert Leroux-Roels, Georgi Shukarev, et al.BMC Infectious Diseases|December 22, 2010
Five years follow-up following two or three doses of a hepatitis B vaccine in adolescents aged 11-15 years: a randomised controlled studyPierre Van Damme, Anna Moiseeva, Igor Marichev, et al.Vaccine|May 4, 2010
Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1-11 yearsHelen Marshall, Terry Nolan, Javier Díez Domingo, et al.Journal of Clinical Monitoring and Computing|January 13, 2019
Predicting postoperative delirium and postoperative cognitive decline with combined intraoperative electroencephalogram monitoring and cerebral near-infrared spectroscopy in patients undergoing cardiac interventionsMona Momeni, Sabrina Meyer, Marie-Agnès Docquier, et al.Pageof 6